City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders. The post City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver appeared first on MedCity News.

There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable. The post The Impending End of Cross-Subsidization appeared first on MedCity News.

The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together. The post How AI Is Connecting MedTech’s Data Without Compromising Compliance  appeared first on MedCity News.

Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members. The post Rosarium Health Forms Home Modification Partnership with Anthem Medi-Cal appeared first on MedCity News.

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with companies such as Bayer and AbbVie. The post AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D appeared first on MedCity News.

What is needed is a fundamentally different operating model for primary care, one designed around continuous engagement rather than episodic encounters. The post Why the Future of Healthcare Depends on Reinventing Primary Care Access appeared first on MedCity News.

[Sponsored] Panelists in the webinar, sponsored by Inovalon, will explore how near real-time surveillance, smart risk prioritization, and closed-loop intervention are shifting stewardship programs to proactive, technology-enabled decision-making that lets pharmacists work at the top of their license. The post The Role of Hospital Stewardship to Improve Outcomes and Manage Costs appeared first on MedCity News.

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy. The post HealthTap Introduces Virtual Primary Care Program for DME Suppliers appeared first on MedCity News.

Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue yet another deal for a rare disease asset. The post Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building appeared first on MedCity News.

Healthleap, a clinical AI platform that works within the EHR to screen hospitalized patients for conditions that might otherwise go undiagnosed, is supporting hospitals in finding at-risk patients sooner. The post Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients appeared first on MedCity News.

Many hospitals are now trying to use AI to automate processes and free up staff time, running simultaneous pilots to perform as many tasks as possible. This quickly leads to pilot sprawl — a state where organizations can no longer even say which agents are still in active use. The post Why Agentic AI Works in Hospitals When You Strip It Down appeared first on MedCity News.

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or external calibration. The post Happy Health’s Cuffless BP Device Wins FDA Clearance appeared first on MedCity News.

Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals. The post Roche Puts Up $100M to Pursue Promising But Competitive New Target in Obesity appeared first on MedCity News.

Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the doctor’s practice. The post Medicare Policy Shouldn’t Be Made in the Shadows appeared first on MedCity News.

Corporate venture funds often chase financial returns while ignoring strategic value. Here’s what it takes to turn healthcare portfolio investments into lasting business impact. The post What Corporate Venture Funds Get Wrong about Strategic Value appeared first on MedCity News.